The results showed increased tumor-infiltrating CD8+ T cells, high levels of secreted IL-2 in the TME and enhanced proliferation of tumor-specific cytotoxic T cells improving immunity and facilitating infiltration of activated T cells into HCC tumors (163). This evidence concerns the gene IL2 and hepatocellular carcinoma.